Results 21 to 30 of about 3,323,629 (269)

Cardiovascular Toxicities of Androgen Deprivation Therapy [PDF]

open access: yesCurrent Treatment Options in Oncology, 2021
Prostate cancer is the second leading cause of cancer death in men, and cardiovascular disease is the number one cause of death in patients with prostate cancer. Androgen deprivation therapy, the cornerstone of prostate cancer treatment, has been associated with adverse cardiovascular events.
Azariyas A. Challa   +12 more
openaire   +2 more sources

What Is Your Choice for Androgen Deprivation Therapy in Metastatic Prostate Carcinoma: Surgical or Medical?

open access: yes, 2022
OBJECTIVE: : At the time of diagnosis, approximately 16.5% of prostate cancer patients are metastatic. The main framework of metastatic prostate cancer treatment is androgen deprivation therapy, which is performed surgically or medically. The aim of this
Kisa, Erdem   +22 more
core   +1 more source

Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer [PDF]

open access: yes, 2001
Objective To examine the role of androgen receptor (AR) gene amplification and aneusomy of the X chromosome in the development of antiandrogen-resistant prostate cancer.
Watters, A.D.   +11 more
core   +1 more source

The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: modifications to the androgen receptor [PDF]

open access: yes, 2005
Prostate cancer is the second most common male malignancy in the western world an increasing incidence in an ageing population. Treatment of advanced prostate cancer relies on androgen deprivation.
Edwards, J., Bartlett, J.M.S.
core   +1 more source

Long-term cardiovascular burden in prostate cancer patients receiving androgen deprivation therapy [PDF]

open access: yes, 2022
Androgen deprivation therapy (ADT), which pharmacologically or surgically suppresses androgen activity, is a key treatment for prostate cancer (PCa).1 However, it is associated with increased cardiovascular risks, including elevated risks of ...
Tse, G.
core  

Outcomes of patients older than 75 years with non-metastatic prostate cancer

open access: yesAsian Journal of Urology, 2017
Objective: Prostate cancer in elderly patients was formerly treated with androgen deprivation therapy. Since the latter of the 1990s new technologies were introduced into treatments, then strategies have varied.
Yoshiyasu Amiya   +8 more
doaj   +1 more source

Bad expression influences time to androgen escape in prostate cancer [PDF]

open access: yes, 2007
<b>OBJECTIVE</b>: To assess the role of selected downstream Bcl-2 family members (Bad, Bax, Bcl-2 and Bcl-xL) in the development of androgen-independent prostate cancer (AIPC), as androgen-deprivation therapy is the treatment of choice in ...
Teo, K.   +4 more
core   +1 more source

The effects of exercise on body composition of prostate cancer patients receiving androgen deprivation therapy: An update systematic review and meta-analysis

open access: yesPLoS ONE, 2022
Androgen deprivation therapy is a common treatment for prostate cancer. However, this therapy is associated with various adverse effects, such as increased body fat and decreased bone mineral density. Exercise may be useful for ameliorating these adverse
Wenjuan Shao   +3 more
doaj   +2 more sources

NON-GENOMIC ANDROGEN ACTION REGULATES PROLIFERATIVE/MIGRATORY SIGNALLING IN STROMAL CELLS.

open access: yesFrontiers in Endocrinology, 2015
Prostate cancer is the major cause of cancer-related death among the male population of Western society, and androgen deprivation therapy represents the first line in prostate cancer treatment. However, although androgen receptor expression is maintained
Marzia eDi Donato   +9 more
doaj   +1 more source

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer

open access: yesNature Communications, 2021
Androgen receptor in prostate cancer (PCa) transcriptionally represses multiple genes including MYC. Here, the authors suggest that increased MYC in response to androgen deprivation contributes to castration-resistant PCa, while decreased MYC may ...
Haiyang Guo   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy